Adverum Biotech
Kalpana Christopher is an experienced professional in the field of technical applications and system analysis, currently serving as the Technical Applications Manager at Adverum Biotechnologies, Inc. since November 2020. Prior roles include IT GxP Business Analyst at Intarcia Therapeutics, Inc., and Business and System Analyst at Stratford School, where Kalpana focused on enrollment-related applications and data analysis. Previous experience includes positions at Revance Therapeutics, GlaxoSmithKline, Takeda Pharmaceuticals, and IBM International Services, emphasizing compliance, validation support, and data management. Kalpana holds a Master's degree in Health Sciences from United States University and a Master's degree in Computer and Information Sciences from Smt. VHD Institute of Home Science.
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.